tirzepatide cardiovascular outcomes trial results july 2025 Effects of on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity 60-Second Journal Club: The SUMMIT

Activates the GHSR receptor in the brain, mimicking ghrelin signaling to stimulate growth hormone release

Acute total renal denervation (T-RDN) Acute T-RDN was performed as described previously [30, 31, 36]

This is the first study to show a clear benefit of GLP-1 receptor agonists on kidney failure or end-stage kidney disease, suggesting they have a key role in kidney-protective and heart-protective treatment for patients with common medical conditions like type 2 diabetes, overweight or obesity with cardiovascular disease, or CKD, he said

According to a study, people who added a lifestyle program alongside semaglutide kept more of their progress after stopping, underscoring why healthy habits make such a big difference